The new falsified medicine directive aims to stem the rise in counterfeit medicines in the supply chain and in addition enable swift recalls of medicines to patient level , if required. Current practices of snipping two tables off 30 pack tablets when the prescription calls for just “28” will have to be addressed as each dispensed pack is to have its own unique identifier. Pharmacies will have to be able to recall medicines from the patients and may have to scan medicines at the point of dispensing to like the medicine with the patient. The effect of this will inevitable incur extra costs and time and will impact on waiting times. It is hoped that minutia of the legislation will be announced later in the year. Who will fund the technology that may be necessary to upgrade some pharmacy and wholesaling systems and will the customers understand why they have to wait longer ? But more importantly will the prescriber start to dispense in whole packs ? Will patients end up with more unused medicines at home or will they become synchronised?